Patents by Inventor Antonio Arulanandam

Antonio Arulanandam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VECTOR AND METHOD FOR TREATING ANGELMAN SYNDROME
    Publication number: 20220152223
    Abstract: One aspect described herein relates to a recombinant adeno-associated virus (rAAV) vector and a method for use thereof or treating Angelman Syndrome. Another aspect described herein is a UBE3A rAAV vector and method for use thereof for treating a UBE3A deficiency, e.g. Angelman syndrome, in humans.
    Type: Application
    Filed: March 20, 2020
    Publication date: May 19, 2022
    Inventors: Antonio ARULANANDAM, Kevin NASH, Edwin WEEBER, Liangxian CAO, Min Jung KIM
  • Azole derivatives and pharmaceutical compositions containing them
    Patent number: 7541375
    Abstract: The invention provides substituted pyrazolidinone compounds, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are useful for a variety of therapies, including treating or preventing various cancers, inflammation, septic shock, preterm labor, infertility, pain, and ischemia, and other diseases and disorders associated with MEK-1 and/or ERK-2 activation.
    Type: Grant
    Filed: July 24, 2007
    Date of Patent: June 2, 2009
    Assignee: Laboratoires Serono SA
    Inventors: Stephen J. Arkinstall, Antonio Arulanandam, Xuliang Jiang, Sharad Magar, Roustem Nabioullin, John Yingsheng Zhang, Peter Blume-Jensen
  • SEQUENTIAL COMBINATION THERAPY
    Publication number: 20080160019
    Abstract: Disclosed are new methods for treatment of angiogenesis-related disorders. Angiogenesis-related disorders are treated by administration of a Tie1 ectodomain-binding agent and a VEGF antagonist agent.
    Type: Application
    Filed: October 17, 2007
    Publication date: July 3, 2008
    Applicant: DYAX CORP.
    Inventors: Clive R. Wood, Daniel T. Dransfield, Antonio Arulanandam, Rakesh K. Jain
  • AZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
    Publication number: 20070293555
    Abstract: The invention provides substituted pyrazolidinone compounds, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are useful for a variety of therapies, including treating or preventing various cancers, inflammation, septic shock, preterm labor, infertility, pain, and ischemia, and other diseases and disorders associated with MEK-1 and/or ERK-2 activation.
    Type: Application
    Filed: July 24, 2007
    Publication date: December 20, 2007
    Applicant: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
    Inventors: Stephen ARKINSTALL, Antonio Arulanandam, Xuliang Jiang, Sharad Magar, Roustem Nabioullin, John Zhang, Peter Blume-Jensen
  • Azole derivatives and pharmaceutical compositions containing them
    Patent number: 7253199
    Abstract: The invention provides substituted pyrazolidinone compounds, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are useful for a variety of therapies, including treating or preventing various cancers, inflammation, septic shock, preterm labor, infertility, pain, and ischemia, and other diseases and disorders associated with MEK-1 and/or ERK-2 activation.
    Type: Grant
    Filed: October 23, 2002
    Date of Patent: August 7, 2007
    Assignee: Applied Research Systems ARS Holding N.V.
    Inventors: Stephen J. Arkinstall, Antonio Arulanandam, Xuliang Jiang, Sharad Magar, Roustem Nabioullin, John Yingsheng Zhang, Peter Blume-Jensen
  • Pharmaceutically active compounds and methods of use
    Publication number: 20050054706
    Abstract: The invention provides substituted pyrazolidinone compounds, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are useful for a variety of therapies, including treating or preventing various cancers, inflammation, septic shock, preterm labor, infertility, pain, and ischemia, and other diseases and disorders associated with MEK-1 and/or ERK-2 activation.
    Type: Application
    Filed: October 23, 2002
    Publication date: March 10, 2005
    Applicant: Applied Research Systems ARS Holding N.V.
    Inventors: Stephen Arkinstall, Antonio Arulanandam, Xuliang Jiang, Sharad Magar, Roustem Nabioullin, John Zhang, Peter Blume-Jensen